ACADIA PHARMACEUTICALS INC
ACADNASDAQ🏆 #1579 by market capUS Equity
$496.68▼ $14.85 (−2.99%)
🌙 After hours$20.28▼ 95.92%Simulated priceTrack ACAD
Get earnings, price moves & breaking news on Telegram
24h▼ 3.0%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$3.54B
Small Cap
📈Revenue Growth (YoY)
+47.0%
High Growth
📊Gross Margin
91.1%
High
💵FCF Margin
17.4%
Healthy
⚖️P/S Ratio
3.1x
Fair
Otter Score
84
Good
ACADIA PHARMACEUTICALS INC
ACADAnalyst Ratings
Price
$496.68
Total
37
Raised
3
Lowered
4
Avg PT
$32.32
H / L
$49 / $15
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
BMO Capital | Reiterated | Outperform | 2026-09-25 | $34.00 | −93.20% |
Citizens | Reiterated | Market Outperform | 2026-09-25 | — | — |
Deutsche Bank | Reiterated | Buy | 2026-09-25 | $31.00 | −93.80% |
HC Wainwright & Co. | Reiterated | Buy | 2026-09-25 | — | — |
Needham | Reiterated | Buy | 2026-09-25 | $35.00 | −93.00% |
Citigroup | Reiterated | Buy | 2026-09-24 | $19.00 | −96.20% |
Morgan Stanley | Reiterated | Equal Weight | 2026-08-25 | $28.00 | −94.40% |
UBS | Reiterated | Buy | 2026-08-17 | $49.00 | −90.10% |
Oppenheimer | Reiterated | Perform | 2026-08-05 | $25.00 | −95.00% |
RBC Capital | Reiterated | Outperform | 2026-08-05 | $37.00 | −92.60% |
Stifel | Reiterated | Hold | 2026-07-21 | — | — |
B of A Securities | Reiterated | Buy | 2026-06-30 | — | — |
Canaccord Genuity | Reiterated | Buy | 2026-06-29 | $36.00 | −92.80% |
JP Morgan | Reiterated | Overweight | 2026-03-04 | $17.00 | −96.60% |
TD Cowen | Reiterated | Buy | 2026-02-26 | — | — |
Mizuho | Upgraded | Neutral → Outperform | 2026-02-23 | — | — |
JMP Securities | Reiterated | Market Outperform | 2025-08-07 | $39.00 | −92.10% |
Goldman Sachs | Reiterated | Sell | 2025-08-07 | $15.00 | −97.00% |
Baird | Reiterated | Outperform | 2025-05-19 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2025-02-27 | $26.00 | −94.80% |
Guggenheim | Downgraded | Buy → Neutral | 2025-01-03 | $20.00 | −96.00% |
Loop Capital | Reiterated | Hold | 2022-11-01 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-08-09 | — | — |
Cowen & Co. | Reiterated | Outperform | 2022-08-08 | $21.00 | −95.80% |
Berenberg | Reiterated | Hold | 2021-06-10 | — | — |
Jefferies | Downgraded | Buy → Hold | 2021-04-06 | — | — |
Raymond James | Downgraded | Strong Buy → Outperform | 2021-03-09 | $14.50 | −97.10% |
Guggenheim Securities | Reiterated | Buy | 2019-12-16 | — | — |
Stifel Nicolaus | Reiterated | Hold | 2019-09-03 | $37.00 | −92.60% |
Leerink Swann | Reiterated | Market Perform → Perform | 2018-11-15 | — | — |
Bank of America | Reiterated | Buy | 2018-10-10 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2018-09-21 | — | — |
Piper Sandler | Upgraded | Neutral → Overweight | 2018-09-21 | $37.00 | −92.60% |
H.C. Wainwright | Reiterated | Buy | 2015-02-24 | $33.00 | −93.40% |
McNicoll Lewis Vlak | Downgraded | Buy → Hold | 2013-08-07 | — | — |
Roth Capital | Reiterated | Buy | 2013-04-11 | — | — |
Ladenburg Thalmann | Reiterated | Buy | 2012-04-30 | — | — |
Institution
BMO Capital
Reiterated · Outperform · 2026-09-25
$34.00
−93.20%
Citizens
Reiterated · Market Outperform · 2026-09-25
—
—
Deutsche Bank
Reiterated · Buy · 2026-09-25
$31.00
−93.80%
HC Wainwright & Co.
Reiterated · Buy · 2026-09-25
—
—
Needham
Reiterated · Buy · 2026-09-25
$35.00
−93.00%
Citigroup
Reiterated · Buy · 2026-09-24
$19.00
−96.20%
Morgan Stanley
Reiterated · Equal Weight · 2026-08-25
$28.00
−94.40%
UBS
Reiterated · Buy · 2026-08-17
$49.00
−90.10%
Oppenheimer
Reiterated · Perform · 2026-08-05
$25.00
−95.00%
RBC Capital
Reiterated · Outperform · 2026-08-05
$37.00
−92.60%
Stifel
Reiterated · Hold · 2026-07-21
—
—
B of A Securities
Reiterated · Buy · 2026-06-30
—
—
Canaccord Genuity
Reiterated · Buy · 2026-06-29
$36.00
−92.80%
JP Morgan
Reiterated · Overweight · 2026-03-04
$17.00
−96.60%
TD Cowen
Reiterated · Buy · 2026-02-26
—
—
Mizuho
Upgraded · Neutral → Outperform · 2026-02-23
—
—
JMP Securities
Reiterated · Market Outperform · 2025-08-07
$39.00
−92.10%
Goldman Sachs
Reiterated · Sell · 2025-08-07
$15.00
−97.00%
Baird
Reiterated · Outperform · 2025-05-19
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2025-02-27
$26.00
−94.80%
Guggenheim
Downgraded · Buy → Neutral · 2025-01-03
$20.00
−96.00%
Loop Capital
Reiterated · Hold · 2022-11-01
—
—
SVB Leerink
Reiterated · Outperform · 2022-08-09
—
—
Cowen & Co.
Reiterated · Outperform · 2022-08-08
$21.00
−95.80%
Berenberg
Reiterated · Hold · 2021-06-10
—
—
Jefferies
Downgraded · Buy → Hold · 2021-04-06
—
—
Raymond James
Downgraded · Strong Buy → Outperform · 2021-03-09
$14.50
−97.10%
Guggenheim Securities
Reiterated · Buy · 2019-12-16
—
—
Stifel Nicolaus
Reiterated · Hold · 2019-09-03
$37.00
−92.60%
Leerink Swann
Reiterated · Market Perform → Perform · 2018-11-15
—
—
Bank of America
Reiterated · Buy · 2018-10-10
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2018-09-21
—
—
Piper Sandler
Upgraded · Neutral → Overweight · 2018-09-21
$37.00
−92.60%
H.C. Wainwright
Reiterated · Buy · 2015-02-24
$33.00
−93.40%
McNicoll Lewis Vlak
Downgraded · Buy → Hold · 2013-08-07
—
—
Roth Capital
Reiterated · Buy · 2013-04-11
—
—
Ladenburg Thalmann
Reiterated · Buy · 2012-04-30
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space